Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Prostate Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 109 articles:
HTML format



Single Articles


    September 2020
  1. UYSAL A, Karaosmanoglu AD, Karcaaltincaba M, Akata D, et al
    Prostatitis, the Great Mimicker of Prostate Cancer: Can We Differentiate Them Quantitatively With Multiparametric MRI?
    AJR Am J Roentgenol. 2020 Sep 9:1-9. doi: 10.2214/AJR.20.22843.
    PubMed     Abstract available


  2. WALKER SM, Mehralivand S, Harmon SA, Sanford T, et al
    Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection.
    AJR Am J Roentgenol. 2020 Sep 2:1-6. doi: 10.2214/AJR.19.22679.
    PubMed     Abstract available


  3. GUPTA RT
    Editorial Comment on "Prevalence of prostate cancer in PI-RADS version 2.1 transition zone 'atypical nodules' upgraded by abnormal diffusion weighted imaging: correlation with MRI-directed TRUS-guided targeted biopsy".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24501.
    PubMed    


  4. COSTA DN, Jia L, Subramanian N, Xi Y, et al
    Prospectively-Reported PI-RADS Version 2.1 Atypical Benign Prostatic Hyperplasia Nodules with Marked Restricted Diffusion ('2+1' Transition Zone Lesions): Clinically Significant Prostate Cancer Detection Rates on Multiparametric MRI.
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24370.
    PubMed     Abstract available


    August 2020
  5. SCHOOTS IG, Barentsz JO, Bittencourt LK, Haider MA, et al
    PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy Naive Men with Suspected Prostate Cancer: A Narrative Review.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24268.
    PubMed     Abstract available


  6. SURASI DSS
    Editorial Comment on "Diagnostic accuracy of 68Ga-PSMA PET/CT for initial detection in patients with suspected prostate cancer: A systematic review and meta-analysis".
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24405.
    PubMed    


  7. MEHRALIVAND S, Harmon SA, Shih JH, Smith CP, et al
    Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI.
    AJR Am J Roentgenol. 2020 Aug 5:1-10. doi: 10.2214/AJR.19.22573.
    PubMed     Abstract available


    July 2020
  8. GEORGE AK, Margolis DJ
    Commentary on "MRI-Targeted, Systematic, and combined Biopsy for Prostate Cancer Diagnosis".
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.24319.
    PubMed    


  9. LIM CS, Abreu-Gomez J, Carrion I, Schieda N, et al
    Prevalence of prostate cancer in PI-RADS version 2.1 transition zone 'atypical nodules' upgraded by abnormal diffusion weighted imaging: correlation with MRI-directed TRUS-guided targeted biopsy.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23932.
    PubMed     Abstract available


  10. WOO S, Vargas HA
    Commentary on "Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study".
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23666.
    PubMed    


  11. SATAPATHY S, Singh H, Kumar R, Mittal BR, et al
    Diagnostic accuracy of (68)Ga-PSMA PET/CT for initial detection in patients with suspected prostate cancer: A systematic review and meta-analysis.
    AJR Am J Roentgenol. 2020 Jul 22. doi: 10.2214/AJR.20.23912.
    PubMed     Abstract available


  12. GAUR S, Mena E, Harmon SA, Lindenberg ML, et al
    Prospective Evaluation of (18)F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI.
    AJR Am J Roentgenol. 2020 Jul 8:1-8. doi: 10.2214/AJR.19.22042.
    PubMed     Abstract available


  13. HOSSEINY M, Shakeri S, Felker ER, Lu D, et al
    3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.
    AJR Am J Roentgenol. 2020 Jul 8:1-7. doi: 10.2214/AJR.19.22455.
    PubMed     Abstract available


  14. BALLAL S, Yadav MP, Bal C
    Reply to "Fact-Checking on (177)Lu-PSMA Nephrotoxicity".
    AJR Am J Roentgenol. 2020;215:W3-W4.
    PubMed    


  15. ASKARI E, Moghadam SZ, Aryana K
    Fact Checking on (177)Lu Prostate-Specific Membrane Antigen Nephrotoxicity.
    AJR Am J Roentgenol. 2020;215:W2.
    PubMed    


    June 2020
  16. WANG Y, Chow DZ, Ebert E, Tajmir S, et al
    Utility of (18)F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (< 0.3 ng/mL) Prostate-Specific Antigen Levels.
    AJR Am J Roentgenol. 2020 Jun 22:1-5. doi: 10.2214/AJR.19.22180.
    PubMed     Abstract available


  17. MARCUS C, Butler P, Bagrodia A, Cole S, et al
    Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
    AJR Am J Roentgenol. 2020 Jun 17:1-10. doi: 10.2214/AJR.19.22404.
    PubMed     Abstract available


  18. ABREU-GOMEZ J, Wu M, McInnes MDF, Thornhill RE, et al
    Shape Analysis of Peripheral Zone Observations on Prostate DWI: Correlation to Histopathology Outcomes After Radical Prostatectomy.
    AJR Am J Roentgenol. 2020;214:1239-1247.
    PubMed     Abstract available


    May 2020
  19. GOTHI R
    Unenhanced CT Can Be Enough to Detect Peripheral Zone Prostate Cancer.
    AJR Am J Roentgenol. 2020;214:W84.
    PubMed    


    April 2020
  20. WALKER SM, Choyke PL, Turkbey B
    What You Need to Know Before Reading Multiparametric MRI for Prostate Cancer.
    AJR Am J Roentgenol. 2020 Apr 7:1-9. doi: 10.2214/AJR.19.22751.
    PubMed     Abstract available


    March 2020
  21. LEE DK, Sung DJ, Kim CS, Heo Y, et al
    Three-Dimensional Convolutional Neural Network for Prostate MRI Segmentation and Comparison of Prostate Volume Measurements by Use of Artificial Neural Network and Ellipsoid Formula.
    AJR Am J Roentgenol. 2020 Mar 24:1-10. doi: 10.2214/AJR.19.22254.
    PubMed     Abstract available


  22. DHATT R, Choy S, Co SJ, Ischia J, et al
    MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score.
    AJR Am J Roentgenol. 2020 Mar 11:1-9. doi: 10.2214/AJR.19.22094.
    PubMed     Abstract available


  23. WIBULPOLPRASERT P, Raman SS, Hsu W, Margolis DJA, et al
    Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2.
    AJR Am J Roentgenol. 2020 Mar 4:1-11. doi: 10.2214/AJR.19.21608.
    PubMed     Abstract available


  24. BHARGAVA P, Ravizzini G, Chapin BF, Kundra V, et al
    Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed?
    AJR Am J Roentgenol. 2020 Mar 4:1-11. doi: 10.2214/AJR.19.21905.
    PubMed     Abstract available


    February 2020
  25. PARK SY, Park BK, Kwon GY
    Diagnostic Performance of Mass Enhancement on Dynamic Contrast-Enhanced MRI for Predicting Clinically Significant Peripheral Zone Prostate Cancer.
    AJR Am J Roentgenol. 2020 Feb 18:1-8. doi: 10.2214/AJR.19.22072.
    PubMed     Abstract available


    January 2020
  26. ROBERTSON MS, Sakellis CG, Hyun H, Jacene HA, et al
    Extraprostatic Uptake of (18)F-Fluciclovine: Differentiation of Nonprostatic Neoplasms From Metastatic Prostate Cancer.
    AJR Am J Roentgenol. 2020 Jan 15:1-8. doi: 10.2214/AJR.19.21894.
    PubMed     Abstract available


  27. KIM SH
    Development and External Validation of Multiparametric MRI-Derived Nomogram to Predict Risk of Pathologic Upgrade in Patients on Active Surveillance for Prostate Cancer.
    AJR Am J Roentgenol. 2020 Jan 8:1-10. doi: 10.2214/AJR.19.22196.
    PubMed     Abstract available


  28. WASHINGTON SL 3RD, Baskin AS, Ameli N, Nguyen HG, et al
    MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.
    AJR Am J Roentgenol. 2020 Jan 8:1-5. doi: 10.2214/AJR.19.21559.
    PubMed     Abstract available


  29. YOSHIDA K, Takahashi N, Karnes RJ, Froemming AT, et al
    Prostatic Remnant After Prostatectomy: MR Findings and Prevalence in Clinical Practice.
    AJR Am J Roentgenol. 2020;214:W37-W43.
    PubMed     Abstract available


  30. TURKBEY B, Czarniecki M, Shih JH, Harmon SA, et al
    Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    AJR Am J Roentgenol. 2020;214:105-113.
    PubMed     Abstract available


    December 2019
  31. WOO S, Han S, Kim TH, Suh CH, et al
    Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2019 Dec 4:1-8. doi: 10.2214/AJR.19.21836.
    PubMed     Abstract available


  32. CHATTERJEE A, Sun C, Oto A
    Reply to "Prostate Cancer Index Lesion Detection and Volume Estimation: Is Dynamic Contrast-Enhanced MRI Really Reliable?"
    AJR Am J Roentgenol. 2019;213:W290.
    PubMed    


  33. VLACHOU PA
    Reply to "Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer: Methodologic Issues to Avoid Misinterpretation".
    AJR Am J Roentgenol. 2019;213:W298.
    PubMed    


  34. SCIALPI M, Scialpi P, Martorana E
    Prostate Cancer Index Lesion Detection and Volume Estimation: Is Dynamic Contrast-Enhanced MRI Really Reliable?
    AJR Am J Roentgenol. 2019;213:W289.
    PubMed    


  35. SABOUR S
    Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer: Methodologic Issues to Avoid Misinterpretation.
    AJR Am J Roentgenol. 2019;213:W297.
    PubMed    


    October 2019
  36. BAKIR B, Onay A, Vural M, Armutlu A, et al
    Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
    AJR Am J Roentgenol. 2019 Oct 31:1-9. doi: 10.2214/AJR.19.21828.
    PubMed     Abstract available


    August 2019
  37. SUBRAMANIAM RM
    Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-(68)Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and (177)Lu-PSMA-617 Therapy.
    AJR Am J Roentgenol. 2019;213:241-242.
    PubMed    


    July 2019
  38. FELKER ER, Raman SS, Lu DSK, Tuttle M, et al
    Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
    AJR Am J Roentgenol. 2019 Jul 30:1-6. doi: 10.2214/AJR.19.21637.
    PubMed     Abstract available


  39. BARRAL M, Lefevre A, Camparo P, Hoogenboom M, et al
    In-Bore Transrectal MRI-Guided Biopsy With Robotic Assistance in the Diagnosis of Prostate Cancer: An Analysis of 57 Patients.
    AJR Am J Roentgenol. 2019 Jul 3:1-9. doi: 10.2214/AJR.19.21145.
    PubMed     Abstract available


    June 2019
  40. BAJGIRAN AM, Mirak SA, Sung K, Sisk AE, et al
    Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
    AJR Am J Roentgenol. 2019 Jun 19:1-9. doi: 10.2214/AJR.19.21365.
    PubMed     Abstract available


  41. SAVIR-BARUCH B, Lovrec P, Solanki AA, Adams WH, et al
    Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
    AJR Am J Roentgenol. 2019 Jun 19:1-8. doi: 10.2214/AJR.19.21153.
    PubMed     Abstract available


  42. HUANG G, Lebovic G, Vlachou PA
    Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer.
    AJR Am J Roentgenol. 2019 Jun 19:1-5. doi: 10.2214/AJR.18.21013.
    PubMed     Abstract available


  43. ABREU-GOMEZ J, Shabana W, McInnes MDF, O'Sullivan JP, et al
    Regional Standardization of Prostate Multiparametric MRI Performance and Reporting: Is There a Role for a Director of Prostate Imaging?
    AJR Am J Roentgenol. 2019 Jun 10:1-7. doi: 10.2214/AJR.19.21111.
    PubMed     Abstract available


  44. OSMANY S, Zaheer S, Bartel TB, Johnston M, et al
    Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers.
    AJR Am J Roentgenol. 2019 Jun 5:1-14. doi: 10.2214/AJR.19.21084.
    PubMed     Abstract available


    May 2019
  45. ABREU-GOMEZ J, Krishna S, Narayanasamy S, Flood TA, et al
    Dynamic Contrast-Enhanced MRI-Upgraded Prostate ImagingReporting and Data System Version 2 Category 3 Peripheral Zone Observations Stratified by a Size Threshold of 15 mm.
    AJR Am J Roentgenol. 2019 May 23:1-8. doi: 10.2214/AJR.18.21005.
    PubMed     Abstract available


    April 2019
  46. LAWHN-HEATH C, Flavell RR, Behr SC, Yohannan T, et al
    Single-Center Prospective Evaluation of (68)Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer.
    AJR Am J Roentgenol. 2019 Apr 30:1-8. doi: 10.2214/AJR.18.20699.
    PubMed     Abstract available


  47. CHATTERJEE A, He D, Fan X, Antic T, et al
    Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study.
    AJR Am J Roentgenol. 2019 Apr 30:1-10. doi: 10.2214/AJR.18.20702.
    PubMed     Abstract available


  48. FELKER ER, Raman SS, Shakeri S, Mirak SA, et al
    Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer.
    AJR Am J Roentgenol. 2019 Apr 30:1-6. doi: 10.2214/AJR.18.20836.
    PubMed     Abstract available


  49. GIGANTI F, Rosenkrantz AB, Villeirs G, Panebianco V, et al
    The Evolution of MRI of the Prostate: The Past, the Present, and the Future.
    AJR Am J Roentgenol. 2019 Apr 30:1-13. doi: 10.2214/AJR.18.20796.
    PubMed     Abstract available


  50. WIBULPOLPRASERT P, Raman SS, Hsu W, Margolis DJA, et al
    Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation.
    AJR Am J Roentgenol. 2019 Apr 17:W1-W10. doi: 10.2214/AJR.18.20113.
    PubMed     Abstract available


  51. YADAV MP, Ballal S, Sahoo RK, Dwivedi SN, et al
    Radioligand Therapy With (177)Lu-PSMA for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2019 Apr 17:1-11. doi: 10.2214/AJR.18.20845.
    PubMed     Abstract available


  52. MEERMEIER NP, Foster BR, Liu JJ, Amling CL, et al
    Impact of Direct MRI-Guided Biopsy of the Prostate on Clinical Management.
    AJR Am J Roentgenol. 2019 Apr 1:1-6. doi: 10.2214/AJR.18.21009.
    PubMed     Abstract available


    March 2019
  53. GREER MD, Shih JH, Lay N, Barrett T, et al
    Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.
    AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536.
    PubMed     Abstract available


  54. SWITLYK MD, Salberg UB, Geier OM, Vlatkovic L, et al
    PTEN Expression in Prostate Cancer: Relationship With Clinicopathologic Features and Multiparametric MRI Findings.
    AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.18.20743.
    PubMed     Abstract available


  55. SACKETT J, Choyke PL, Turkbey B
    Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?
    AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.19.21178.
    PubMed     Abstract available


    February 2019
  56. BARKOVICH EJ, Shankar PR, Westphalen AC
    A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores.
    AJR Am J Roentgenol. 2019 Feb 26:1-8. doi: 10.2214/AJR.18.20571.
    PubMed     Abstract available


  57. CHOI MH, Kim CK, Lee YJ, Jung SE, et al
    Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    AJR Am J Roentgenol. 2019 Feb 19:1-8. doi: 10.2214/AJR.18.20498.
    PubMed     Abstract available


  58. HOTKER AM, Dappa E, Mazaheri Y, Ehdaie B, et al
    The Influence of Background Signal Intensity Changes on Cancer Detection in Prostate MRI.
    AJR Am J Roentgenol. 2019 Feb 4:1-7. doi: 10.2214/AJR.18.20295.
    PubMed     Abstract available


    January 2019
  59. TANAKA T, Froemming AT, Panda A, Edmonson HA, et al
    Safety and Image Quality of 1.5-T Endorectal Coil Multiparametric MRI of the Prostate or Prostatectomy Fossa for Patients With Pacemaker or Implantable Cardioverter-Defibrillator.
    AJR Am J Roentgenol. 2019 Jan 30:1-8. doi: 10.2214/AJR.18.20266.
    PubMed     Abstract available


    December 2018
  60. FREIFELD Y, Diaz de Leon A, Xi Y, Pedrosa I, et al
    Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate.
    AJR Am J Roentgenol. 2018 Dec 27:1-6. doi: 10.2214/AJR.18.20320.
    PubMed     Abstract available


  61. SUN C, Chatterjee A, Yousuf A, Antic T, et al
    Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    AJR Am J Roentgenol. 2018 Dec 12:1-6. doi: 10.2214/AJR.18.20147.
    PubMed     Abstract available


  62. KANG Z, Min X, Weinreb J, Li Q, et al
    Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Dec 4:W1-W9. doi: 10.2214/AJR.18.20103.
    PubMed     Abstract available


    November 2018
  63. CHATTERJEE A, Tokdemir S, Gallan AJ, Yousuf A, et al
    Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate.
    AJR Am J Roentgenol. 2018 Nov 7:1-6. doi: 10.2214/AJR.18.19742.
    PubMed     Abstract available


  64. TURCO S, Lavini C, Heijmink S, Barentsz J, et al
    Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
    AJR Am J Roentgenol. 2018;211:W242-W251.
    PubMed     Abstract available


  65. COSTA DN, Xi Y, Aziz M, Passoni N, et al
    Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
    AJR Am J Roentgenol. 2018 Nov 1:1-8. doi: 10.2214/AJR.18.19937.
    PubMed     Abstract available


    October 2018
  66. METSER U, Chan R, Veit-Haibach P, Ghai S, et al
    Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
    AJR Am J Roentgenol. 2018 Oct 17:W1-W5. doi: 10.2214/AJR.18.20495.
    PubMed     Abstract available


  67. JENA A, Taneja R, Taneja S, Singh A, et al
    Improving Diagnosis of Primary Prostate Cancer With Combined (68)Ga-Prostate-Specific Membrane Antigen-HBED-CC Simultaneous PET and Multiparametric MRI and Clinical Parameters.
    AJR Am J Roentgenol. 2018 Oct 9:1-8. doi: 10.2214/AJR.18.19585.
    PubMed     Abstract available


    September 2018
  68. WOO S, Suh CH, Kim SY, Cho JY, et al
    Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Sep 21:W1-W15. doi: 10.2214/AJR.18.19880.
    PubMed     Abstract available


    August 2018
  69. DIAZ DE LEON A, Leyendecker JR, Otero-Muinelo S, Grewal H, et al
    Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.
    AJR Am J Roentgenol. 2018 Aug 30:1-6. doi: 10.2214/AJR.17.19172.
    PubMed     Abstract available


  70. WANG X, Tu N, Qin T, Xing F, et al
    Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    AJR Am J Roentgenol. 2018 Aug 7:W1-W8. doi: 10.2214/AJR.17.19249.
    PubMed     Abstract available


    July 2018
  71. LEE SJ, Oh YT, Jung DC, Cho NH, et al
    Combined Analysis of Biparametric MRI and Prostate-Specific Antigen Density: Role in the Prebiopsy Diagnosis of Gleason Score 7 or Greater Prostate Cancer.
    AJR Am J Roentgenol. 2018 Jul 17:W1-W7. doi: 10.2214/AJR.17.19253.
    PubMed     Abstract available


  72. WESTIN C, Chatterjee A, Ku E, Yousuf A, et al
    MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
    AJR Am J Roentgenol. 2018 Jul 11:1-10. doi: 10.2214/AJR.17.19201.
    PubMed     Abstract available


  73. QI L, Wu CJ, Zhang J, Bao ML, et al
    Construction of a Preoperative Radiologic-Risk Signature for Predicting the Pathologic Status of Prostate Cancer at Radical Prostatectomy.
    AJR Am J Roentgenol. 2018 Jul 11:1-7. doi: 10.2214/AJR.17.19360.
    PubMed     Abstract available


  74. SADOUGHI N, Krishna S, McInnes MDF, Flood TA, et al
    ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    AJR Am J Roentgenol. 2018 Jul 11:W1-W8. doi: 10.2214/AJR.17.18958.
    PubMed     Abstract available


    June 2018
  75. HOPE TA, Afshar-Oromieh A, Eiber M, Emmett L, et al
    Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.
    AJR Am J Roentgenol. 2018 Jun 27:1-9. doi: 10.2214/AJR.18.19957.
    PubMed     Abstract available


  76. NIU XK, Chen XH, Chen ZF, Chen L, et al
    Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Jun 12:1-10. doi: 10.2214/AJR.17.18946.
    PubMed     Abstract available


  77. SCIALPI M, Aisa MC, D'Andrea A, Martorana E, et al
    Simplified Prostate Imaging Reporting and Data System for Biparametric Prostate MRI: A Proposal.
    AJR Am J Roentgenol. 2018 Jun 12:1-4. doi: 10.2214/AJR.17.19014.
    PubMed     Abstract available


  78. MCEVOY SH, Raeside MC, Chaim J, Ehdaie B, et al
    Preoperative Prostate MRI: A Road Map for Surgery.
    AJR Am J Roentgenol. 2018 Jun 12:W1-W9. doi: 10.2214/AJR.17.18757.
    PubMed     Abstract available


  79. ORTMAN M, Kasson M, Sidana A
    Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2018;210:W268.
    PubMed    


  80. SHERIDAN AD, Weinreb JC, Spektor M
    Reply to "Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI".
    AJR Am J Roentgenol. 2018;210:W269.
    PubMed    


    May 2018
  81. SI Y, Liu RB
    Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 May 29:1-11. doi: 10.2214/AJR.17.18934.
    PubMed     Abstract available


    April 2018
  82. KIM JG, Kim CK, Kim JH
    Prebiopsy Multiparametric MRI With Cancer-Negative Findings in Men With Suspected Prostate Cancer: Evaluation Using Prostate Imaging Reporting and Data System Version 2.
    AJR Am J Roentgenol. 2018 Apr 30:1-6. doi: 10.2214/AJR.17.18926.
    PubMed     Abstract available


  83. LEE MS, Moon MH, Kim YA, Sung CK, et al
    Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
    AJR Am J Roentgenol. 2018 Apr 27:1-7. doi: 10.2214/AJR.17.18684.
    PubMed     Abstract available


    March 2018
  84. TANEJA S, Jena A, Taneja R, Singh A, et al
    Effect of Combined (68)Ga-PSMAHBED-CC Uptake Pattern and Multiparametric MRI Derived With Simultaneous PET/MRI in the Diagnosis of Primary Prostate Cancer: Initial Experience.
    AJR Am J Roentgenol. 2018 Mar 12:1-8. doi: 10.2214/AJR.17.18881.
    PubMed     Abstract available


    February 2018
  85. COSTA DN, Passoni NM, Leyendecker JR, de Leon AD, et al
    Diagnostic Utility of a Likert Scale Versus Qualitative Descriptors and Length of Capsular Contact for Determining Extraprostatic Tumor Extension at Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2018 Feb 28:1-7. doi: 10.2214/AJR.17.18849.
    PubMed     Abstract available


  86. SHERIDAN AD, Nath SK, Aneja S, Syed JS, et al
    MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2018 Feb 28:W1-W8. doi: 10.2214/AJR.17.18680.
    PubMed     Abstract available


    January 2018
  87. WOO S, Suh CH, Kim SY, Cho JY, et al
    The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis.
    AJR Am J Roentgenol. 2018 Jan 30:W1-W15. doi: 10.2214/AJR.17.18481.
    PubMed     Abstract available


  88. METSER U, Berlin A, Halankar J, Murphy G, et al
    (18)F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer.
    AJR Am J Roentgenol. 2018 Jan 11:1-6. doi: 10.2214/AJR.17.18567.
    PubMed     Abstract available


    December 2017
  89. NIU XK, Chen ZF, Chen L, Li J, et al
    Clinical Application of Biparametric MRI Texture Analysis for Detection and Evaluation of High-Grade Prostate Cancer in Zone-Specific Regions.
    AJR Am J Roentgenol. 2017 Dec 8:W1-W8. doi: 10.2214/AJR.17.18494.
    PubMed     Abstract available


    November 2017
  90. PARVINIAN A, Martin-Macintosh EL, Goenka AH, Durski JM, et al
    11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas.
    AJR Am J Roentgenol. 2017 Nov 15:1-5. doi: 10.2214/AJR.17.18312.
    PubMed     Abstract available


  91. SHERIDAN AD, Nath SK, Syed JS, Aneja S, et al
    Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2017 Nov 7:1-11. doi: 10.2214/AJR.17.18516.
    PubMed     Abstract available


    October 2017
  92. TAMADA T, Huang C, Ream JM, Taffel M, et al
    Apparent Diffusion Coefficient Values of Prostate Cancer: Comparison of 2D and 3D ROIs.
    AJR Am J Roentgenol. 2017 Oct 18:1-5. doi: 10.2214/AJR.17.18495.
    PubMed     Abstract available


  93. KRISHNA S, McInnes M, Lim C, Lim R, et al
    Comparison of Prostate Imaging Reporting and Data System Versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    AJR Am J Roentgenol. 2017 Oct 5:W1-W9. doi: 10.2214/AJR.17.17964.
    PubMed     Abstract available


    September 2017
  94. WOO S, Suh CH, Kim SY, Cho JY, et al
    Head-To-Head Comparison Between High- and Standard-b-Value DWI for Detecting Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2017 Sep 27:1-10. doi: 10.2214/AJR.17.18480.
    PubMed     Abstract available


    August 2017
  95. FELKER ER, Raman SS, Margolis DJ, Lu DSK, et al
    Risk Stratification Among Men With Prostate Imaging Reporting and Data System Version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
    AJR Am J Roentgenol. 2017 Aug 31:1-6. doi: 10.2214/AJR.17.18008.
    PubMed     Abstract available


  96. WU CJ, Zhang YD, Bao ML, Li H, et al
    Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
    AJR Am J Roentgenol. 2017 Aug 23:1-7. doi: 10.2214/AJR.16.17781.
    PubMed     Abstract available


  97. WOO S, Suh CH, Kim SY, Cho JY, et al
    Shear-Wave Elastography for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    AJR Am J Roentgenol. 2017 Aug 10:1-9. doi: 10.2214/AJR.17.18056.
    PubMed     Abstract available


  98. JADVAR H
    Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.
    AJR Am J Roentgenol. 2017;209:277-288.
    PubMed     Abstract available


    July 2017
  99. SHERIDAN AD, Nath SK, Huber S, Rosasco S, et al
    Role of MRI in the Use of an Absorbable Hydrogel Spacer in Men Undergoing Radiation Therapy for Prostate Cancer: What the Radiologist Needs to Know.
    AJR Am J Roentgenol. 2017 Jul 25:1-3. doi: 10.2214/AJR.17.18026.
    PubMed     Abstract available


  100. KIM SH, Choi MS, Kim MJ, Kim YH, et al
    Validation of Prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in Prostate Cancer Diagnosis.
    AJR Am J Roentgenol. 2017 Jul 13:1-6. doi: 10.2214/AJR.16.17629.
    PubMed     Abstract available


    June 2017
  101. GLAZER DI, Mayo-Smith WW, Sainani NI, Sadow CA, et al
    Interreader Agreement of Prostate Imaging Reporting and Data System Version 2 Using an In-Bore MRI-Guided Prostate Biopsy Cohort: A Single Institution's Initial Experience.
    AJR Am J Roentgenol. 2017 Jun 28:W1-W7. doi: 10.2214/AJR.16.17551.
    PubMed     Abstract available


  102. MORGAN VA, Parker C, MacDonald A, Thomas K, et al
    Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
    AJR Am J Roentgenol. 2017 Jun 13:1-9. doi: 10.2214/AJR.17.17790.
    PubMed     Abstract available


  103. GANESHAN D, Aparicio AM, Morani A, Kundra V, et al
    Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.
    AJR Am J Roentgenol. 2017 Jun 7:1-6. doi: 10.2214/AJR.16.17214.
    PubMed     Abstract available


  104. MATSUOKA Y, Ishioka J, Tanaka H, Kimura T, et al
    Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer.
    AJR Am J Roentgenol. 2017 Jun 1:W1-W9. doi: 10.2214/AJR.16.17163.
    PubMed     Abstract available


  105. PURYSKO AS, Bittencourt LK, Bullen JA, Mostardeiro TR, et al
    Accuracy and Interobserver Agreement for Prostate Imaging Reporting and Data System, Version 2, for the Characterization of Lesions Identified on Multiparametric MRI of the Prostate.
    AJR Am J Roentgenol. 2017 Jun 1:1-7. doi: 10.2214/AJR.16.17289.
    PubMed     Abstract available


    April 2017
  106. SEO JW, Shin SJ, Taik Oh Y, Jung DC, et al
    PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer.
    AJR Am J Roentgenol. 2017 Apr 18:W1-W9. doi: 10.2214/AJR.16.16981.
    PubMed     Abstract available


    February 2017
  107. VENDERINK W, Govers TM, de Rooij M, Futterer JJ, et al
    Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
    AJR Am J Roentgenol. 2017 Feb 22:1-6. doi: 10.2214/AJR.16.17322.
    PubMed     Abstract available


    December 2016
  108. ROSENKRANTZ AB, Ayoola A, Hoffman D, Khasgiwala A, et al
    The Learning Curve in Prostate MRI Interpretation: Self-Directed Learning Versus Continual Reader Feedback.
    AJR Am J Roentgenol. 2016 Dec 27:W1-W9. doi: 10.2214/AJR.16.16876.
    PubMed     Abstract available


    August 2016
  109. KIRSCH AJ, Coakley FV, Foster BR
    A Modified Approach for Transgluteal Prostate Biopsy in Patients Without Rectal Access.
    AJR Am J Roentgenol. 2016;207:W20.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: